Influenza A(H1N1)09: New Zealand's response to the pandemic threat

New Zealand Medical Journal

Volumn 122, Issue 1298, 2009, Pages

  Jennings, Lance C ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; OSELTAMIVIR; ZANAMIVIR;

EDITORIAL; HEALTH CARE PLANNING; INFECTION CONTROL; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; NEW ZEALAND; PANDEMIC; PATIENT CARE; PHARMACEUTICAL CARE; PUBLIC HEALTH SERVICE;

EID: 68349113528     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Editorial

References (15)

1. Ministry of Health. New Zealand Pandemic Action Plan, September. Wellington: MoH; 2006. http://www.moh.govt.nz/moh.nsf/indexmh/ nz-influenza-pandemic-action-plan-2006.
2. World Health Organization. World now at start of 2009 influenza pandemic. Geneva: WHO; 2009. http://www.who.int/mediacentre/news/ statements/2009/h1n1_pandemic_phase6_20090611/en/index.html
3. Novel, Swine Origin A(H1N1) Virus Investigation Team. Emergence of a Novel Swine-Origin Influenza A(H1N1) in Humans. New Engl J Med 2009;361:1-11
4. Fraser C, Donnelly CA, Cauchemez S et al. Pandemic potential of a strain of influenza A(H1N1): Early findings. Science 2009. http://www.sciencemag.org/cdi/rapidpdf/117062v2.pdf
5. Jennings L. Avian influenza: A public health risk for New Zealand. NZMJ 2004;117(1192). http://www.nzma.org.nz/journal/117-1192/843.
6. Jennings L. New Zealand's preparedness for the next influenza pandemic NZMJ 2005:118(1211). http://www.nzma.org.nz/journal/118-1211/ 1343/.
7. Hurt AC, Baas C, Deng Y-M, et al. Performance of influenza rapid point-of-care tests in the detection of swine lineage A(H1N1) influenza viruses. Influenza Other Respir Viruses 2009;3:171-6.
8. World Health Organization. WHO Interim Protocol: Rapid operations to contain the initial emergence of pandemic influenza. Geneva: WHO; 2007. http://www.who.int/csr/disease/avian_influenza/guidelines/ reviftprotocol/en/index.html.
9. McLeod M, Kelly H, Wilson N, Baker M. Border control measures in the influenza pandemic plans of six South Pacific nations: A critical review. N Z Med J 2008;121:62-72. http://www.nzmj.com/journal/ 121-1278/3163/
10. Duncan AR, Priest PC, Jennings LC, et al. Screening for Influenza Infection in International Airline Travelers. American Journal of Public Health 2009 [In Press].
11. Jennings L. How Can Influenza Vaccines and Antivirals be Best Delivered in the Industrialized World? New Zealand. Presentation at: Infectious Diseases Society of America: US Seasonal and Pandemic Influenza 2008. Arlington, Virginia, USA (18-20 May) 2008. http://www.hivma.org/ WorkArea/showcontent.aspx?id=11358
12. ECDC. First isolation of a secondary oseltamivir-resistant A(H1N1)v strain in Denmark. 1 July 2009. http://www.ecdc.europa.eu/en/files/ pdf/Health_topics/0907_Influenza_AH1N1v_Resistance_ TA_Oseltamivir.pdf
13. Jennings LC, Monto AS, Chan PKS, et al. Stockpiling pre-pandemic influenza vaccines: A new cornerstone of pandemic preparedness plans. The Lancet Infect Dis 2008;8:650-8.
14. Ghedin E, Fitch A, Boyne A, et al. Mixed Infection and the Genesis of Influenza Diversity. PNAS 2009[In Press].
15. Wilson N, Baker MG, Jennings LC. The clioepidemiology of pandemic influenza and next steps for pandemic influenza research in New Zealand. N Z Med J. 2008;121:(1284). http://www.nzma.org.nz/journal/121-1284/ 3307/